Cargando…
Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma
This cohort study assesses the risk of breakthrough SARS-CoV-2 infection and hospitalization among fully vaccinated patients with multiple myeloma.
Autores principales: | Wang, Lindsey, Berger, Nathan A., Xu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611483/ https://www.ncbi.nlm.nih.gov/pubmed/34812850 http://dx.doi.org/10.1001/jamanetworkopen.2021.37575 |
Ejemplares similares
-
Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma
por: Aleman, Adolfo, et al.
Publicado: (2021) -
SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma
por: Sgherza, Nicola, et al.
Publicado: (2021) -
SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care
por: Wang, Lindsey, et al.
Publicado: (2022) -
Predictors of hospitalization and severe disease due to breakthrough SARS‐CoV‐2 infection in fully vaccinated individuals
por: Johnson, Steven, et al.
Publicado: (2022) -
Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)